A
ANGO icon

AlphaQuest’s AngioDynamics ANGO Stock Holding History

AlphaQuest’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-33,677
Closed -$432K – 132
2025
Q4 		$432K Buy
33,677
+10,813
+47% +$133K 0.02% 934
2025
Q3 		$255K Buy
22,864
+22,863
+2,286,300% +$221K 0.02% 1261
2025
Q2 		$10 Hold
1
– – ﹤0.01% 1979
2025
Q1 		$9 Sell
1
-176
-99% -$1.85K ﹤0.01% 2016
2024
Q4 		$1.62K Sell
177
-36,472
-100% -$268K ﹤0.01% 1604
2024
Q3 		$285K Buy
+36,649
New +$265K 0.03% 917
2024
Q1 		– Sell
-8,778
Closed -$68.8K – 1644
2023
Q4 		$68.8K Buy
+8,778
New +$60.9K 0.01% 834

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

AlphaQuest's ANGO Position: Q1 2026 in Review

AlphaQuest sold out of AngioDynamics (ANGO) in Q1 2026, closing a stake of 33,677 shares — an estimated $432K sold.

AlphaQuest first reported a position in ANGO in Q4 2023 and held it in 7 quarters. The position peaked at $432K in Q4 2025. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • AlphaQuest reported no remaining AngioDynamics position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 33,677 AngioDynamics shares in Q1 2026, an estimated $432K.
  • AlphaQuest first reported a position in AngioDynamics in Q4 2023 and held it in 7 quarters.
  • AlphaQuest's AngioDynamics position peaked at $432K in Q4 2025.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.